In contrast, patient cohorts from Japan report a higher prevalence, with over one-third of JDM patients testing positive for anti-MDA5 antibodies, and more than half of those developing RP-ILD [2, 5]. The gene discussed is IFIH1; the disease is retinitis pigmentosa 1.